98%
921
2 minutes
20
When people are ostrasized (i.e., rejected and excluded) by either an outgroup or an ingroup, they may either withdraw or engage in compensatory activities designed to reaffirm their social identity as a group member. The authors proposed here that individual differences in identity fusion (an index of familial orientation toward the group) would moderate the tendency for people to display such compensatory activity. Consistent with this reasoning, the results of four experiments showed that irrevocable ostracism increased endorsement of extreme, pro-group actions (fighting and dying for the ingroup) among fused persons but not among nonfused persons. This effect emerged when an outgroup ostracized fused individuals due either to their nationality (Experiment 1) or their personal preferences (Experiment 2). Similarly, ostracism by the ingroup amplified the tendency for fused persons to both endorse extreme pro-group actions, refuse to leave the group (Experiment 3), and donate money to an ingroup member (Experiment 4). Finally, compensatory activities emerged even when ostracism was based on being "too good" for the group, suggesting that a desire for self-enhancement does not mediate such activities (Experiment 4).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0146167211424580 | DOI Listing |
Body Image
September 2025
Gender Studies Programme, The Chinese University of Hong Kong, Hong Kong.
Engaging in the gay community provides support and affirmation, but it is often overlooked that some sexual minority men may experience stress from status-based competition within the mainstream gay community. These pressures are more prevalent among sexual minority men with lower social and sexual status, who are frequently devalued and excluded by other members of the community. Such experiences can be more psychologically impactful than rejection by mainstream society.
View Article and Find Full Text PDFRen Fail
December 2025
Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Background: Tacrolimus is key in renal transplantation. This study evaluated optimal intrapatient variability (IPV) and time in therapeutic range (TTR) thresholds and association with renal outcomes.
Methods: This single-center study (1999-2018) had a mean follow-up of 3 years.
Clin Transl Sci
September 2025
Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Tacrolimus is an immunosuppressive agent with difficult dosing due to a narrow therapeutic index and large interpatient pharmacokinetic variability, for which CYP3A5 variation plays a role. Tacrolimus/CYP3A5 pharmacogenetic guidelines exclude liver transplant patients with a donor/recipient CYP3A5 mismatch. We sought to determine the influence of donor vs.
View Article and Find Full Text PDFJ Vasc Interv Radiol
August 2025
Department of Radiology, Seoul National University Hospital, Seoul, Korea; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea. Electronic address:
Purpose: To detail the process of resin-based same-day planning/treatment radioembolization for treating liver cancer ≥ 5 cm and to compare it with multiday radioembolization.
Materials And Methods: This single-center retrospective study included 80 patients who tried same-day radioembolization and 120 patients who received multiday radioembolization with resin microspheres between January 2022 and December 2023. For same-day radioembolization, once operators determined the required number and activity of vials, daughter vials were dispensed from a mother vial in the hospital nuclear medicine facility and then delivered to the angiography room.
World J Transplant
September 2025
Department of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.
Background: Gastroesophageal reflux disease has been shown to contribute to allograft injury and rejection outcomes in lung transplantation through a proposed mechanism of aspiration, inflammation, and allograft injury. The value of pre-transplant reflux testing in predicting reduction in pulmonary function after lung transplantation is unclear. We hypothesized that increased reflux burden on pre-transplant reflux testing is associated with pulmonary function decline following lung transplant.
View Article and Find Full Text PDF